BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Rational Design of Sulfonyl-γ-AApeptides as Highly Potent HIV-1 Fusion Inhibitors with Broad-Spectrum Activity.EBI
University of South Florida
Acyclic antiviralsBDB
Janssen Pharmaceutica
5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (No. 5)
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Compounds and compositions for treating HIV with derivatives of BetulinBDB
Glaxosmithkline